Pennsylvania State University College of Medicine, known simply as Penn State College of Medicine is the medical school of Penn State.

During the past decade, Penn State College of Medicine conducted 46 clinical trials. In the 10-year time frame, 46 clinical trials started and 21 clinical trials were completed, i.e. on average, 45.7% percent of trials that started reached the finish line to date. In the past 5 years, 25 clinical trials started and 13 clinical trials were completed. i.e. 52% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Penn State College of Medicine" #1 sponsor was "Milton S. Hershey Medical Center" with 33 trials, followed by "Jaeb Center for Health Research" with 7 trials sponsored, "Yale University" with 5 trials sponsored, "Medical College of Wisconsin" with 2 trials sponsored and "Memorial Sloan Kettering Cancer Center" with 2 trials sponsored. Other sponsors include 27 different institutions and companies that sponsored additional 35 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Penn State College of Medicine" #1 collaborator was "Penn State University" with 9 trials as a collaborator, "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 8 trials as a collaborator, "National Cancer Institute (NCI)" with 6 trials as a collaborator, "National Eye Institute (NEI)" with 6 trials as a collaborator and "University of Colorado, Denver" with 6 trials as a collaborator. Other collaborators include 93 different institutions and companies that were collaborators in the rest 64 trials.

According to Clinical.Site data, the most researched conditions in "Penn State College of Medicine" are "Diabetic Macular Edema" (3 trials), "Diabetic Retinopathy" (3 trials), "Hypertension" (3 trials), "Infertility" (3 trials) and "Pregnancy" (3 trials). Many other conditions were trialed in "Penn State College of Medicine" in a lesser frequency.

Most popular intervention types in "Penn State College of Medicine" are "Drug" (37 trials), "Behavioral" (15 trials), "Other" (14 trials), "Procedure" (6 trials) and "Device" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (9 trials), "Lenalidomide" (2 trials), "Reduced Nicotine Content Cigarettes" (2 trials), "Tacrolimus" (2 trials) and "Triamcinolone Acetonide" (2 trials). Other intervention names were less common.

The vast majority of trials in "Penn State College of Medicine" are 69 trials for "All" genders, 9 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Penn State College of Medicine". undefined are not yet recruiting, 8 are recruiting, 8 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 53 completed trials in Penn State College of Medicine, 1 suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Penn State College of Medicine, 4 "Phase 1" clinical trials were conducted, 11 "Phase 2" clinical trials and 25 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 27 trials that are defined as “Not Applicable".